Wednesday, July 8, 2026

pharma · Alagille Syndrome · Progressive Familial Intrahepatic Cholestasis (PFIC) · MIRM

Mirum Pharmaceuticals International

NovaPharmaNews editorial coverage mentioning Mirum Pharmaceuticals International — regulatory, clinical, and market analysis.

989 E Hillsdale Blvd., Suite 300, Foster City, CA 94404, US HQ
2018 Founded
436 Employees
Public company Type
MIRM · NYSE Ticker
Company details
Status
Public
HQ
989 E Hillsdale Blvd., Suite 300, Foster City, CA 94404, US
Founded
2018
Employees
436
Programs
25
Drugs
10
Patents
4
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Mirum Pharmaceuticals International — regulatory, clinical, and market coverage.

NovaPharmaNews editorial coverage mentioning Mirum Pharmaceuticals International — regulatory, clinical, and market analysis.

No coverage yet

We have not published news or analysis mentioning Mirum Pharmaceuticals International yet.

Back to company overview →